(Q37625670)

English

Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies

scientific article published on 30 October 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

1 reference

Europe PubMed Central

Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

based on heuristic

inferred from title

author name string

Roland Klingenberg

1

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Göran K Hansson

2

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

publication date

30 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

2838-2844

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Major risk factors as antecedents of fatal and nonfatal coronary heart disease events

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

TNF/TNFR family members in costimulation of T cell responses

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Immunological and inflammatory functions of the interleukin-1 family

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Increased plasma concentrations of interleukin-18 in acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Cytokines in atherosclerosis: pathogenic and regulatory pathways

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Myocardial reperfusion injury.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Oral fingolimod (FTY720) for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

C-reactive protein levels and outcomes after statin therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Osteoprotegerin promotes fibrous cap formation in atherosclerotic lesions of ApoE-deficient mice--brief report.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

5-lipoxygenase: regulation and possible involvement in atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Inflammation, atherosclerosis, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Cytokine network and T cell immunity in atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Isolation, expansion, and characterization of human natural and adaptive regulatory T cells

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Vaccination against atherosclerosis? Induction of atheroprotective immunity

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Soluble CD40 Ligand in Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Genetic and Acquired Inflammatory Conditions Are Synergistically Associated With Early Carotid Atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHP477

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37625670&oldid=1716024214"